Baxter Bros Inc’s Teva Pharmaceuticals TEVA Stock Holding History

Baxter Bros Inc’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3,466	Closed	-$216K	–	113
2015 Q1	$216K	Buy	+3,466	New	+$202K	0.08%	106

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Baxter Bros Inc's TEVA Position: Q2 2015 in Review

Baxter Bros Inc sold out of Teva Pharmaceuticals (TEVA) in Q2 2015, closing a stake of 3,466 shares — an estimated $216K sold.

Baxter Bros Inc first reported a position in TEVA in Q1 2015 and held it in 1 quarter. The position peaked at $216K in Q1 2015. 818 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

Baxter Bros Inc reported no remaining Teva Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Baxter Bros Inc sold 3,466 Teva Pharmaceuticals shares in Q2 2015, an estimated $216K.
Baxter Bros Inc first reported a position in Teva Pharmaceuticals in Q1 2015 and held it in 1 quarter.
Baxter Bros Inc's Teva Pharmaceuticals position peaked at $216K in Q1 2015.
818 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2015.

Based on Baxter Bros Inc's 13F filing for Q2 2015, filed 7 Jul 2015.